Volume 8, Issue 1 (1-2020)                   JoMMID 2020, 8(1): 19-23 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Nasiri M, Fozouni L. Human Amniotic Fluid: a New Challenge for the Control of Seborrheic Dermatitis. JoMMID 2020; 8 (1) :19-23
URL: http://jommid.pasteur.ac.ir/article-1-239-en.html
Human Amniotic Fluid: a New Challenge for the Control of Seborrheic Dermatitis
Mohadeseh Nasiri , Leila Fozouni *
Department of Biology, Gorgan Branch, Islamic Azad University, Gorgan, Iran
Abstract:   (2354 Views)

Introduction: Seborrheic dermatitis is a skin condition that has become widespread in the recent decades. This study aimed to investigate the antimicrobial effect of amniotic fluid of pregnant women on the growth of ketoconazole-resistant Malassezia species isolated from patients with seborrheic dermatitis. Methods: We obtained human amniotic fluid from 20 pregnant women during amniocentesis and cesarean delivery at hospitals of Gonbad-e Kavus, northeastern Iran. Malassezia isolates were collected from 120 patients suspected of seborrheic dermatitis and were identified using species-specific biochemical tests. Antibiotic susceptibility and minimum inhibitory concentration (MIC) of Malassezia isolates against ketoconazole were determined by the broth microdilution method. Also, the antifungal effect of various concentrations of amniotic fluid on ketoconazole-resistant Malassezia isolates was assayed using the disk diffusion method. Results:  The mean MIC of ketoconazole against Malassezia isolates was 0.3 μg/mL, with the most changes observed at 0.5 μg and 1 μg/mL. Ketoconazole  inhibited the growth of Malassezia isolates completely, at a concentration of 8 μg/mL. Moreover, amniotic fluid showed inhibitory effects on 60% of ketoconazole-resistant Malassezia furfur isolates and 45% of Malassezia globosa isolates. There was a significant correlation between amniotic fluid concentration and the diameter of the growth inhibition zone (P<0.01). Conclusion: Our findings indicated that amniotic fluid could exhibit favorable dose-dependent antifungal activity against ketoconazole-resistant Malassezia isolates from patients with seborrheic dermatitis. Further studies are required to confirm the efficiency of amniotic fluid for the treatment of such infections.

Keywords: Dermatitis, Seborrheic, Amniotic Fluid, Antifungal Agent
Full-Text [PDF 293 kb]   (1260 Downloads)    
Type of Study: Original article | Subject: Anti-microbial agents, resistance and treatment protocols
Received: 2020/02/10 | Accepted: 2020/05/30 | Published: 2020/01/11
References
1. Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL Jr. Skin diseases associated with Malassezia species. J Am Acad Dermatol. 2004; 51 (5): 785-98. [DOI:10.1016/j.jaad.2003.12.034]
2. Falahati M, Pakshir K, Alinejad Talesh Kh. Separation and Identification of Different Species of Malassezia in Patients Referred to Medical Centers in Shiraz. Razi J Med Sci. 2005; 12 (45): 133-40.
3. Faergemann J. Atopic dermatitis and fungi. Clin Microbiol Rev. 2002; 15 (4): 545-63. [DOI:10.1128/CMR.15.4.545-563.2002]
4. Yurayart C, Nuchnoul N, Moolkum P, Jirasuksiri S, Niyomtham W, et al. Antifungal agent susceptibilities and interpretation of Malassezia pachydermatis and Candida parapsilosis isolated from dogs with and without seborrheic dermatitis skin. Med Mycol. 2013; 51 (7): 721-30. [DOI:10.3109/13693786.2013.777165]
5. Prohic A. Distribution of Malassezia species in seborrhoeic dermatitis: correlation with patients' cellular immune status. Mycoses. 2010; 53 (4): 344-9. [DOI:10.1111/j.1439-0507.2009.01713.x]
6. Shemer A, Kaplan B, Nathansohn N, Grunwald MH, Amichai B, Trau H. Treatment of moderate to severe facial seborrheic dermatitis with itraconazole: an open non-comparative study. Isr Med Assoc J. 2008; 10 (6): 417-18.
7. Sangwan VS, Basu S. Antimicrobial properties of amniotic membrane. Br J Ophthalmol. 2011; 95 (1): 1-2. [DOI:10.1136/bjo.2010.184259]
8. Urvashi Biswas, P. M. Tumane and D. D. Wasnik. Antibacterial Activity of Human Amniotic Fluid. Eur J Biomed Pharm Sci. 2016; 3 (2): 381-4.
9. King AE, Paltoo A, Kelly RW, Sallenave JM, Bocking AD, Challis JR. Expression of natural antimicrobials by human placenta and fetal membranes. Placenta. 2007; 28 (2-3): 161-9. [DOI:10.1016/j.placenta.2006.01.006]
10. Kjaergaard N, Hein M, Hyttel L, Helmig RB, Schønheyder HC, Uldbjerg N, et al. Antibacterial properties of human amnion and chorion in vitro. Eur J Obstet Gynecol Reprod Biol. 2001; 94 (2): 224-9. [DOI:10.1016/S0301-2115(00)00345-6]
11. Bäck O, Faergemann J, Hörnqvist R. Pityrosporum folliculitis: a common disease of the young and middle-aged. J Am Acad Dermatol. 1985; 12 (1): 56-61. [DOI:10.1016/S0190-9622(85)70009-6]
12. Rex JH; Clinical Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: Approved standard. 3rd ed. Pennsylvania: Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
13. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic sensitivity testing by a standardized single disk method. Am J Clin Pathol. 1966; 45 (4): 493-6. [DOI:10.1093/ajcp/45.4_ts.493]
14. Fozouni L, Taghizadeh F, Kiaei E. Anti-Microbial Effect of Aloevera Extract on Clotrimazole-Resistant Malassezia Furfur Strains Isolated from Patients with Seborrheic Dermatitis in the City of Sari. Ann Mil Health Sci Res. 2018; 16 (2): e82841. [DOI:10.5812/amh.82841]
15. Shokri H. Occurrence and distribution of Malassezia species on skin and external ear canal of horses. Mycoses. 2016; 59 (1): 28-33. [DOI:10.1111/myc.12430]
16. Falahati M, Pakshir K, Alinejad Talesh K. Separation and Identification of Different Species of Malassezia in Patients Referred to Medical Centers in Shiraz. Razi J Med Sci. 2005; 12 (45): 133-40.
17. Nakabasyashi A, Sei Y, Guillot J. Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med Mycol. 2000; 337-41. [DOI:10.1080/714030958]
18. Petry V, Tanhausen F, Weiss L, Milan T, Mezzari A, Magda Blessmann W. Identification of Malassezia yeast species isolated from patients with pityriasis versicolor. An Bras Dermatol. 2011; 86 (4): 803-6. [DOI:10.1590/S0365-05962011000400032]
19. Ramadán S,Sortino M, Bulacio L, MarozziML, López C, Ramos L. Prevalence of Malassezia species in patients with pityriasis versicolor in Rosario, Argentina. Rev Iberoam Micol. 2012; 29 (1): 14-19. [DOI:10.1016/j.riam.2011.03.001]
20. Archana BR, Beena PM, Kumar S. Study of the distribution of Malassezia species in patients with pityriasis versicolor in Kolar Region, Karnataka. Indian J Dermatol. 2015; 60 (3): 321. [DOI:10.4103/0019-5154.156436]
21. Shams-Ghahfarokhi M, Shokoohamiri MR, Amirrajab N, Moghadasi B, Ghajari A, Zeini F, et al. In vitro antifungal activities of Allium cepa, Allium sativum and ketoconazole against some pathogenic yeasts and dermatophytes. Fitoterapia. 2006; 77 (4): 321-3. [DOI:10.1016/j.fitote.2006.03.014]
22. Shams Ghahfarrokhi M, Razzaghparast A, Yadegari M, RazzaghiAbyaneh M. Antifungal effects of Fluconazole, Itraconazole and Ketoconazole in intact forms and also combinations to each other against some pathogenic yeasts. Horizon Med Sci. 2008; 13 (4): 29-38
23. Nazeri M, Moniri R, ShokoohAmiri M R, Moayeri MR, Moraveji SA. Antifungal activities of fluconazole and ketoconazole agents. J Mazandaran Univ Med Sci. 2009; 19 (69): 22-7.
24. Kalarestaghi A, Hajheydari Z, Hedayati M, Shokohi T. in Patients Referred to Dermatology Clinic of Booali Hospital from Sari and Susceptibility of Isolated Species to Ketoconazole, Miconazole and Clotrimazole. J Mazandaran Univ Med Sci. 2011; 21 (81): 11-19.
25. Rojas FD, Sosa Mde L, Fernández MS, Cattana ME, Córdoba SB, Giusiano GE. Antifungal susceptibility of Malassezia furfur, Malassezia sympodialis, and Malassezia globosa to azole drugs and amphotericin B evaluated using a broth microdilution method. Med Mycol. 2014; 52 (6): 641-6. [DOI:10.1093/mmy/myu010]
26. Mao Y, Pierce J, Singh-Varma A, Boyer M, Kohn J, Reems JA. Processed human amniotic fluid retains its antibacterial activity. J Transl Med. 2019; 17: 1-9. [DOI:10.1186/s12967-019-1812-8]
27. Yadav MK, Go YY, Kim SH, Chae SW, Song JJ. Antimicrobial and Antibiofilm Effects of Human Amniotic/Chorionic Membrane Extract on Streptococcus pneumoniae. Front Microbiol. 2017; 8: 1-17. [DOI:10.3389/fmicb.2017.01948]
28. Zare-Bidaki M, Sadrinia S, Erfani S, Afkar E, Ghanbarzade N. Antimicrobial Properties of Amniotic and Chorionic Membranes: A Comparative Study of Two Human Fetal Sacs. J Reprod Infertil. 2017; 18 (2): 218-24.
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.